Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1923 1
1937 1
1945 75
1946 39
1947 41
1948 54
1949 70
1950 107
1951 140
1952 134
1953 120
1954 99
1955 106
1956 94
1957 77
1958 73
1959 30
1960 1
1961 6
1963 88
1964 115
1965 138
1966 110
1967 115
1968 144
1969 143
1970 107
1971 113
1972 92
1973 81
1974 78
1975 103
1976 117
1977 96
1978 108
1979 99
1980 115
1981 98
1982 102
1983 103
1984 126
1985 120
1986 139
1987 142
1988 161
1989 165
1990 190
1991 167
1992 190
1993 190
1994 184
1995 187
1996 173
1997 221
1998 256
1999 251
2000 353
2001 400
2002 375
2003 487
2004 540
2005 608
2006 605
2007 647
2008 796
2009 797
2010 872
2011 1002
2012 1032
2013 1136
2014 1432
2015 1717
2016 2277
2017 2232
2018 2184
2019 2313
2020 2384
2021 2536
2022 2569
2023 2511
2024 1146

Text availability

Article attribute

Article type

Publication date

Search Results

35,802 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Jung-Sik
Page 1
Uveal Melanoma Metastasis.
Rossi E, Croce M, Reggiani F, Schinzari G, Ambrosio M, Gangemi R, Tortora G, Pfeffer U, Amaro A. Rossi E, et al. Cancers (Basel). 2021 Nov 13;13(22):5684. doi: 10.3390/cancers13225684. Cancers (Basel). 2021. PMID: 34830841 Free PMC article. Review.
Nevertheless, this knowledge has so far not led to innovative therapies for the successful treatment of UM metastases or for adjuvant therapy, leaving survival after diagnosis of metastatic UM almost unaltered in decades. ...Immune checkpoint blockers, despite the g …
Nevertheless, this knowledge has so far not led to innovative therapies for the successful treatment of UM metastases or for adjuvant …
Utilization Management.
Giardino AP, Wadhwa R. Giardino AP, et al. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Jul 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32809641 Free Books & Documents.
The type of UM that occurs before the clinical event is called prior authorization or "pre-auth." If UM occurs during clinical care for a patient admitted to a facility, then this type of UM is called a concurrent review. ...
The type of UM that occurs before the clinical event is called prior authorization or "pre-auth." If UM occurs during clinical …
Spliceosome Mutations in Uveal Melanoma.
Nguyen JQN, Drabarek W, Yavuzyigitoglu S, Medico Salsench E, Verdijk RM, Naus NC, de Klein A, Kiliç E, Brosens E. Nguyen JQN, et al. Int J Mol Sci. 2020 Dec 15;21(24):9546. doi: 10.3390/ijms21249546. Int J Mol Sci. 2020. PMID: 33333932 Free PMC article. Review.
Uveal melanoma (UM) is the most common primary intraocular malignancy of the eye. ...SF3B1 is the most common mutated spliceosome gene and in UM it is associated with late-onset metastasis. This review summarizes the genetic and epigenetic insights of spliceosome mu …
Uveal melanoma (UM) is the most common primary intraocular malignancy of the eye. ...SF3B1 is the most common mutated spliceosome gen …
Immunotherapy for uveal melanoma.
Kim DW, Anderson J, Patel SP. Kim DW, et al. Melanoma Manag. 2016 Jun;3(2):125-135. doi: 10.2217/mmt-2015-0006. Epub 2016 May 19. Melanoma Manag. 2016. PMID: 30190881 Free PMC article. Review.
Uveal melanoma (UM) is a rare cancer with a high mortality rate. In comparison to cutaneous melanoma, UM has unique immunological features. ...This is considered a major obstacle for successful immunotherapy in UM. However, a growing body of evidence suggests …
Uveal melanoma (UM) is a rare cancer with a high mortality rate. In comparison to cutaneous melanoma, UM has unique immunologi …
The biology of uveal melanoma.
Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, Pfeffer U. Amaro A, et al. Cancer Metastasis Rev. 2017 Mar;36(1):109-140. doi: 10.1007/s10555-017-9663-3. Cancer Metastasis Rev. 2017. PMID: 28229253 Free PMC article. Review.
G protein signaling has been shown to activate the YAP/TAZ pathway independent of HIPPO, and conventional signaling via the mitogen-activated kinase pathway probably also contributes to UM development and progression. Several lines of evidence indicate that inflammation an …
G protein signaling has been shown to activate the YAP/TAZ pathway independent of HIPPO, and conventional signaling via the mitogen-activate …
DNA Methylation and Uveal Melanoma.
Yang ZK, Yang JY, Xu ZZ, Yu WH. Yang ZK, et al. Chin Med J (Engl). 2018 Apr 5;131(7):845-851. doi: 10.4103/0366-6999.228229. Chin Med J (Engl). 2018. PMID: 29578129 Free PMC article. Review.
Specifically, a high percentage of promoter methylation of RASSF1A was observed in UM cell lines and/or patients with UM. Promoter methylation of RASSF1A was also associated with the development of metastasis. ...CONCLUSIONS: Our review reveals the complex mechanism …
Specifically, a high percentage of promoter methylation of RASSF1A was observed in UM cell lines and/or patients with UM. Prom …
Treatment of Uveal Melanoma.
Shoushtari AN, Carvajal RD. Shoushtari AN, et al. Cancer Treat Res. 2016;167:281-93. doi: 10.1007/978-3-319-22539-5_12. Cancer Treat Res. 2016. PMID: 26601868 Review.
Uveal melanoma (UM) comprises approximately 5 % of all melanoma diagnoses in the USA each year. Approximately half of patients with UM eventually develop metastases, most commonly involving the liver. ...
Uveal melanoma (UM) comprises approximately 5 % of all melanoma diagnoses in the USA each year. Approximately half of patients with …
Mutational landscape in Uveal Melanoma.
Mastronikolis S, Adamopoulou M, Papouliakos S, Manoli A, Katsinis S, Makri O, Monastirioti AE, Tsiambas E, Georgakopoulos C. Mastronikolis S, et al. J BUON. 2021 Jul-Aug;26(4):1194-1197. J BUON. 2021. PMID: 34564968 Free article. Review.
UM is the most common primary ocular malignancy demonstrating increased rates, especially in middle-aged white (Caucasian) populations. ...In the current molecular review, we present specific mutations -as a landscape- that are implicated in UM genetic substrate and …
UM is the most common primary ocular malignancy demonstrating increased rates, especially in middle-aged white (Caucasian) population …
Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma.
Yang C, Wang R, Hardy P. Yang C, et al. Cancers (Basel). 2021 Oct 16;13(20):5192. doi: 10.3390/cancers13205192. Cancers (Basel). 2021. PMID: 34680340 Free PMC article. Review.
Uveal melanoma (UM) is the most common adult intraocular cancer, and metastatic UM remains deadly and incurable. ...As understanding of epigenetic dysregulation in the oncogenesis of UM has increased, the abnormal expression of microRNAs (miRNAs) has been fou …
Uveal melanoma (UM) is the most common adult intraocular cancer, and metastatic UM remains deadly and incurable. ...As underst …
An update on inflammation in uveal melanoma.
Liau S, Wang JZ, Zagarella E, Paulus P, Dang NHQH, Rawling T, Murray M, Zhou F. Liau S, et al. Biochimie. 2023 Sep;212:114-122. doi: 10.1016/j.biochi.2023.04.013. Epub 2023 Apr 25. Biochimie. 2023. PMID: 37105300 Review.
Uveal melanoma (UM) is the primary ocular cancer with upto 50% of patients dying from metastasis. ...Despite decades of investigation regarding the role UM tumour microenvironment has played, that of inflammation in UM progression remains poorly understood. . …
Uveal melanoma (UM) is the primary ocular cancer with upto 50% of patients dying from metastasis. ...Despite decades of investigation …
35,802 results
You have reached the last available page of results. Please see the User Guide for more information.